Adderall shortage Archives

The Adderall Shortage Is Getting Worse in the Ways That Matter Most

May 8, 2026May 8, 2026 - by Michael Phillips - Leave a Comment

The ongoing Adderall shortage, now in its fourth year, continues to worsen despite a DEA production quota increase. Structural issues in supply chains, pharmaceutical exits from the generic market, and a high demand fueled by telehealth prescriptions contribute to the crisis. Patients resort to unsafe alternatives, highlighting the inadequacy of regulatory responses.

Adderall Shortage Persists Into 2026 — Modest DEA Quota Increase Offers Limited Relief

January 27, 2026January 26, 2026 - by Michael Phillips - 1 Comment

The ongoing Adderall shortage in the U.S. has persisted since late 2022, causing inconsistent access for patients. Although the DEA increased production limits for stimulants, manufacturing delays and supply chain issues complicate availability. Patients are urged to plan refills early while advocates continue to push for systemic changes to address this crisis.

The Adderall Shortage Isn’t an Accident—It’s a Policy Failure

December 22, 2025December 22, 2025 - by Michael Phillips - 1 Comment

The ongoing Adderall shortage, affecting Americans with ADHD since late 2022, results from regulatory failures and mismatched supply and demand. Rising ADHD diagnoses, increased telehealth access, and reduced stigma highlighted the need for flexible production quotas. Patients face significant disruptions, impacting their performance and well-being, while effective governance remains elusive.